Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

Autor: Oosting, S.F., van der Veldt, A.A.M., Fehrmann, R.S.N., Bhattacharya, A., van Binnendijk, R.S., GeurtsvanKessel, C.H., Dingemans, A.-M.C., Smit, E.F., Hiltermann, T.J.N., den Hartog, G., Jalving, M., Westphal, T.T., de Wilt, F., Ernst, S.M., Boerma, A., van Zijl, L., Rimmelzwaan, G.F., Kvistborg, P., van Els, C.A.C.M., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.E.

Publikováno v: In ESMO Open August 2023 8(4)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment.

Autor: van der Veldt AAM; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, Netherlands; Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl., Oosting SF; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., GeurtsvanKessel CH; Department of Viroscience, Erasmus Medical Centre, Rotterdam, Netherlands., van Binnendijk RS; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Dingemans AC; Department of Respiratory Medicine Erasmus Medical Centre, Rotterdam, Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Hiltermann TJN; Department of Pulmonary Diseases, University Medical Centre Groningen, Amsterdam, Netherlands., Hartog GD; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Westphal TT; Comprehensive Cancer Organization the Netherlands, Utrecht, Netherlands., Bhattacharya A; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., de Wilt F; Department of Viroscience, Erasmus Medical Centre, Rotterdam, Netherlands., Ernst SM; Department of Respiratory Medicine Erasmus Medical Centre, Rotterdam, Netherlands., Boerma A; Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., van Zijl L; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Rimmelzwaan GF; Research Centre for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany., Kvistborg P; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Els CACM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Rots NY; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., van Baarle D; Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.

Publikováno v: ESMO open [ESMO Open] 2023 Feb; Vol. 8 (1), pp. 100785. Date of Electronic Publication: 2023 Jan 10.